| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.1M | +346.8% |
| Cost of Revenue | $1.0M | +272.6% |
| Gross Profit | $42K | +213.6% |
| R&D Expense | $164K | -62.2% |
| SG&A Expense | $909K | +15.7% |
| Operating Income | -$3.6M | +31.6% |
| Interest Expense | $899K | +56.2% |
| Net Income | -$4.8M | +53.4% |
| EPS (Diluted) | -$0.04 | +63.6% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $87K | +99.3% |
| Inventory | $1.6M | +348.7% |
| Current Assets | $1.8M | -39.4% |
| Total Assets | $3.1M | -8.4% |
| Current Liabilities | $12.4M | +39.1% |
| Total Liabilities | $13.1M | +34.2% |
| Stockholders' Equity | -$10.0M | -57.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$1.5M | +35.9% |
| Capital Expenditures | $298K | +55.1% |
| Investing Cash Flow | -$298K | -55.1% |
| Financing Cash Flow | $798K | -77.1% |
| Free Cash Flow | -$1.8M | +29.0% |